|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Lin, Han-Fei | James Aiping Lee | Wu, Hsueh-Chun | (03)666-9596 | 1F., No.10, Yanfa 2nd Road, Hsinchu Science ParkHsinChu 30076, TAIWAN(R.O.C) | 2008/11/10 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | EASYWELL BIOMEDICALS, INC. (EASYWELL BIOMEDICALS) aims to become one of the world leaders in healthcare. we have established three business sectors: pharmaceuticals, regenerative medicine, and medical devices. EASYWELL BIOMEDICALS’s management team consists of professionals with comprehensive experience in platform technology development, regulatory affairs strategies, product commercialization, and global marketing. Our full medical product line covers measurement, diagnostics, and therapeutic treatment. We intend to provide a complete set of high-quality medical products to meet the growing demand of the global medical market. |
Market Information ( 2024/04/17 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
87.734 | 67.00 | 65.40 | 67.00 | 1.60 | 70 | .00 | 0 | 0 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/04/17) |
TPEx measures adopted (2024/04/17) |
With warrants | Can be shorted or margined? | Detail | |||||
變更交易 | Y | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |